Skip to content

Primary Palliative Care - a Feasibility Cluster Trial

Primary Palliative Care - a Feasibility Cluster Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07737899
Acronym
PrimPal
Enrollment
30
Registered
2026-07-30
Start date
2026-10-01
Completion date
2027-08-31
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer, Chronic Kidney Disease (Stages 4 and 5), Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure Chronic, Palliative Care, Primary Palliative Care

Keywords

Palliative care, Primary Palliative Care, General practice, Family medicine, Feasibility study, Cluster randomized controlled trial, Complex intervention, Chronic disease

Brief summary

This feasibility cluster-controlled randomized trial (RCT) evaluates a complex intervention for the delivery of primary palliative care in Family Health Units (FHUs). The intervention consists of training General Practitioners (GPs) in palliative care through a 30 hour e-learning program and implementing a structured consultation model (4 consultations over 12 weeks) for adult patients with advanced chronic illness. One FHU will receive the intervention and one FHU will follow usual care. The primary goal is to assess feasibility metrics (GP adherence, patient recruitment rate, and patient retention rate), which will inform the design of a subsequent full-scale cluster RCT.

Detailed description

Background: Demographic ageing and the rising burden of chronic disease have dramatically increased the need for palliative care. Most patients with palliative care needs are cared for in primary health care (PHC) settings, yet GPs often lack training and systematic tools to identify and manage these patients. The Principal Investigator developed a complex intervention combining GP training and a new consultation model during doctoral research, demonstrating promising results (reduction in physical and psychological symptoms) in a before-after study (published in Palliative Medicine, DOI: 10.1177/02692163231219682). The present feasibility trial is the next methodological step before undertaking a full-scale cluster RCT. Design: Feasibility cluster-controlled RCT with an embedded qualitative component (mixed-methods). Randomisation occurs at the cluster (FHU) level. Two FHUs from ULS Coimbra (central Portugal) will be recruited: one allocated to the intervention arm and one to the control (usual care) arm. Intervention: GPs in the intervention FHU will complete a 30hour e-learning training programme covering palliative care communication, symptom management, and patient assessment/control. After training, each GP will apply the new structured consultation model to recruited patients over 12 weeks (4 consultations). The model is grounded in the 4th edition of the National Consensus Project's Clinical Practice Guidelines for Quality Palliative Care and WONCA's core competencies for GPs in palliative care. Control: GPs in the control FHU will follow usual care without any specific palliative care training or structured consultation model. Participants: Adult patients (≥18 years) on the list of recruited GPs with a diagnosis of: advanced-stage neoplasm (metastatic cancer), COPD GOLD III/IV, Congestive Heart Failure NYHA III/IV, or Chronic Kidney Disease stage IV/V. Feasibility outcomes: GP implementation rate (primary), patient recruitment rate, and patient retention rate will be assessed at baseline (T0), week 6 (T1), and week 12 (T2). Qualitative data will be collected through interviews with GPs and patients to explore perceived barriers and benefits of the intervention. Significance: Results will be used to refine the intervention and study procedures, and to power a future definitive cluster RCT.

Interventions

OTHERPrimary Palliative Care Complex Intervention (PrimPal)

1. GPs will receive an e-learning palliative care training programme with a 30-h load, including topics such as the role of communication, the main problems and symptoms of patients with palliative care needs and how to assess and control them. Additionally, the programme covered how to apply the newly developed medical consultation model and how to use the Integrated Palliative Care Outcome Scale (IPOS) patient version 2. Primary palliative care consultation model divided into five areas (1) summarizing clinical information, (2) objective symptoms' management, (3) assessment and coding of chronic diseases and symptoms, (4) planning clinical approach and (5) addressing other problems/concerns - 4 consultations over 12 weeks.

Sponsors

University of Coimbra
Lead SponsorOTHER
Unidade Local de Saúde de Coimbra, EPE
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years or older. * Enrolled as a patient on the list of a recruited General Practitioner in one of the participating Family Health Units. * Diagnosed with one or more of the following advanced chronic conditions: * Advanced-stage neoplasm (metastatic/stage IV cancer); * Chronic Obstructive Pulmonary Disease (COPD) - GOLD classification III or IV; * Congestive Heart Failure (CHF) - New York Heart Association (NYHA) functional classification III or IV; * Chronic Kidney Disease (CKD) - stage IV or V.

Exclusion criteria

* Refusal to provide informed consent or to participate in the study at any point. * Disease severity requiring urgent medical intervention (acute crisis/emergency care need at time of recruitment).

Design outcomes

Primary

MeasureTime frameDescription
GP Feasibility Rate (Implementation Rate)12 weeks (from start of intervention to end of consultation cycle - Week 12 / T2)Percentage of GPs in the intervention arm who successfully implement the new consultation model with their recruited patients (excluding failures due to reasons unrelated to the physician, e.g., patient death or withdrawal). Feasibility is considered demonstrated if ≥70% of GPs complete the model with at least 80% of their recruited patients.

Secondary

MeasureTime frameDescription
Patient Recruitment RateBaseline (T0) - during recruitment periodPercentage of contacted eligible patients who agree to participate in the study.
Patient Retention RateWeek 12 (T2)Percentage of enrolled patients who complete all 4 consultations and remain in the study until week 12.
Perceived Barriers to ImplementationWeek 12 (T2) - end of interventionQualitative exploration of obstacles experienced by GPs and patients in the implementation of the intervention, assessed via semi-structured interviews
Perceived Benefits of the InterventionWeek 12 (T2) - end of interventionQualitative exploration of the benefits perceived by GPs and patients from the intervention, assessed via semi-structured interviews.

Countries

Portugal

Contacts

CONTACTCarlos S Cardoso, PhD
carlosseicacardoso@uc.pt00351 239 857 700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026